National Yang Ming Chiao Tung University

Faculty

Faculty

Chang, Yih-Hisn / 張懿欣

Department of Biotechnology and Laboratory Science in Medicine

 02-2826-7000 #67955;#65836
 02-2821-9240
 cyh@nycu.edu.tw

Current Position

Professor, Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University

 

 

Office

Room 320, 3F, Biomedical Science and Engineering Building

 

 

 

Academic Degrees

Ph.D., Institute of Microbiology and Immunology, NYCU
B.S., Department of Medical Technology, Kaohsiung Medical University

 

 

Experience

Professor/Director, Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University

Visiting Scholar, Faculty of Health, Education and Life Sciences, Birmingham City University, UK
Visiting Scholar, Department of Oncology, University of Sheffield, UK
Visiting Scholar, Erasmus Mundus International Master Program, Encole Normale Supreme du Cachan Paris, France
Professor/Director, School of Medical Technology and Biotechnology, Chung Shan Medical University

 

 

Specialty

Molecular Diagnostics, Metabolic Syndrome, Diabetes Mellitus, Microbiology/Immunology

 

 

 

Research Interests

Diabetes mellitus, metabolic syndrome, obesity, immunology, molecular diagnostics

 

 

Selected Publications

  1. Chuang CC, Chen YH, Chu FY, Ho HL, Chang FP, Yang CP, Lo YL, Chen CJ, and Chang YH*. Temporal effects of lipid oversupply on energy metabolism and mitochondrial homeostasis in hepatocytes. International Journal of Medical Sciences 2025; 22: 3664-3681. doi: 10.7150/ijms.104128
  2. Ho KT, Chu FY, Lin YK, Chin HH, Yang SC, yang CP, Chang YH*. Interleukin-4 ameliorates macrophage lipid stress through promoting cholesterol efflux and lipid homeostasis. Cytokine. 2025 Apr;188:156869. doi: 10.1016/j.cyto.2025.156869. Epub 2025 Feb 14. PMID: 39954486.
  3. Chen SM, Hsiao CW, Chen YJ, Hong CJ, Lin JC, Yang CP, Chang YH*. Interleukin-4 inhibits the hypothalamic appetite control by modulating the insulin-AKT and JAK-STAT signaling in leptin mutant mice. Environ Toxicol 2024 Jul;39(7):3980-3990. doi: 10.1002/tox.24264. Epub 2024 Apr 10. PMID: 38597583.
  4. Chang YH, Chang SW, Hsu WT, Yang CP, Lo YL, Chen CJ, Tsai HF, Shiau MY*. Adipogenesis-coupled CRMP2 functional profile in metabolic homeostasis and imbalance. Biomedicines 2022, 10, 2603. https://doi.org/10.3390/biomedicines10102603
  5. Chang YH, Yang HJ, Chen HW, Hsiao CW, Hsieh YC, Chan YW, Chang, SW, Hwang WL, Chen WS, Cheng HH, et al. Characterization of collapsin response mediator protein 2 in colorectal cancer progression in subjects with diabetic comorbidity. Cells 2022;11,727.
  6. Cheng YJ, Liu CC, Chu FY, Yang CP, Chuang CW, Hsiao CW, Shiau MY, Lee HT, Tsai JN, Chang YH*. Oxygenated water inhibits adipogenesis and attenuates hepatic steatosis in high-fat diet induced obese mice. International Journal of Molecular Sciences 2020;21,5493.
  7. Lin SY, Yang CP, Wang YY, Hsiao CW, Chen WY, Liao SL, Lo YL, Chang YH, Hone CJ, Chen CJ*. Interleukin-4 improves metabolic abnormalities in leptin-deficient and high-fat diet mice. International Journal of Molecular Sciences 2020;21,4451.
  8. Chang YH#, Tsai JN#, Chang SW, Hsu WT, Yang CP, Hsiao CW, Shiau MY. Regulation of adipogenesis and lipid deposits by collapsin response mediator protein 2. International Journal of Molecular Sciences 2020;21,2172.
  9. Shiau MY, Chuang PH, Yang CP, Hsiao CW, Chang SW, Chang KY, Liu TM, Chen HW, Chuang CC, Yuan SY, and Chang YH*. Mechanism of interleukin-4 reducing lipid deposit by regulating hormone-sensitive lipase. Scientific Reports 2019;9:Article number:11974.
  10. Chang YH#, Tsai JN#, Chen TZ, Ho KT, Cheng HY, Hsiao CW, and Shiau MY*. Interleukin-4 promotes myogenesis and boosts myocyte insulin efficacy. Mediators of Inflammation 2019;2019: Article ID 4182015,14 pages (#equal 1st author).
  11. Yang CP#, Shiau MY#, Lai YR, Ho KT, Hsiao CW, Chen CJ, Lo YL, and Chang YH*. Anti-inflammatory cytokine interleukin-4 boosts insulin-induced energy deposits by enhancing glucose uptake and lipogenesis in hepatocytes. Oxidative Medicine and Cellular Longevity 2018, Article ID 6923187.
  12.   Shiau MY#, Lu HF#, Chang YH#, Chiu YC and Shih YL. Characterization of proteins regulated by interleukin-4 in 3T3-L1 adipocytes. SpringerPlus 2015;4:242.
  13. Tsao CH, Shiau MY, Chuang PH, Chang YH*, Hwang J. Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis. Journal of Lipid Research 2014;55:385-397.
  14.   Chang YH, Huang CN and Shiau MY*. Association of IL-4 receptor gene polymorphisms with high density lipoprotein cholesterol. Cytokine 2012;59:309-312.
  15.   Chang YH, Ho KT, Lu SH, Huang CN and Shiau MY#. Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4. International Journal of Obesity 2012;36:993-998.
  16. Ho KT#, Shiau MY#, Chang YH#, Chen CM#, Yang SC and Huang CN. Association of IL-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus. Metabolism 2010;59:1717. (#equal contribution as the first author)
  17.  Norman PJ, Abi-Rached L, Gendzekhadze K, Hammond JA, Moesta AK, Sharma D, Graef T, McQueen KL, Guethlein LA, Carrington CV, Chandanayingyong D, Chang YH, Crespí C, Saruhan-Direskeneli G, Hameed K, Kamkamidze G, Koram K, Layrisse Z, Matamoros N, Milà J, Park MH, Pitchappan RM, Ramdath D, Shiau MY, Stephens HAF, Struik S, Tyan D, Verity DH, Vaughan RW, Davis RW, Fraser PA, Riley EM, Ronaghi1 M, Parham1 P. Meiotic recombination generates rich diversity in NK cell receptor genes, alleles and haplotypes. Genome Research 2009;19:757-769. (International Collaboration)
  18.  Norman PJ, Abi-Rached L, Gendzekhadze K, Korbel D, Gleimer M, Rowley D, Bruno D, Carrington CVF, Chandanayingyong D, Chang YH, Crespí C, Saruhan-Direskeneli G, Fraser PA, Hameed K, Kamkamidze G, Koram KA, Layrisse Z, Matamoros N, Milà J, Park MH, Pitchappan RM, Ramdath D, Shiau MY, Stephens HAF, Struik S, Verity DH, Vaughan RW, Tyan D, Davis RW, Riley EM, Ronaghi M, Parham P*. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nature Genetics 2007;39:1092-1099. (International Collaboration)
  19. Chen QY, Jackson N, Vargas A, Chalew S, Rao J, Batzer M, Lan MS, Chang YH, Mokhashi M, Liu D. Identification of three genomic haplotypes 5’ to the human CD1D gene and their distribution in four ethnic groups. Tissue Antigens 2003;62:442-448. (International Collaboration)
  20.  Chang YH, Hwang J, Shang HF, and Tsai ST*: Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM. Diabetes 1996;45:408-414.